Last reviewed · How we verify
NCT03462823: ACLROCS
Use of an Osteoconductive Scaffold in ACL-Reconstruction
NA trial testing Osteoconductive scaffold-hamstring tendon composite repair in ACL - Anterior Cruciate Ligament Rupture in 56 participants. Participants enrolled and being followed up; not accepting new ones.
29 January 2024
Quick facts
| Lead sponsor | Sandro Fucentese |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 56 |
| Start date | 29 April 2017 |
| Primary completion | 29 January 2024 |
| Estimated completion | 29 December 2025 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Osteoconductive scaffold-hamstring tendon composite repair
- Hamstring tendon-only repair
Conditions studied
- ACL - Anterior Cruciate Ligament Rupture — all drugs for ACL - Anterior Cruciate Ligament Rupture →
- ACL — all drugs for ACL →
- ACL Injury — all drugs for ACL Injury →
Sponsor
Sandro Fucentese
Who can join
Adults 18 to 60, any sex, with ACL - Anterior Cruciate Ligament Rupture or ACL. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Primary objective of the study is to evaluate efficacy of the surgical technique for ACL reconstruction using an osteoconductive scaffold, enlaced into the hamstring tendon autograft, compared to the traditional technique.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Osteoconductive Scaffold Placed at the Femoral Tunnel Aperture in Hamstring Tendon ACL Reconstruction: A Randomized Controlled Trial.
Götschi T, Hodel S, Kühne N, Bachmann E, et al · · 2023 · cited 3× · PMID 37347015 · DOI 10.1177/23259671231174478
Verify or expand the search:
- PubMed search for NCT03462823
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for ACL - Anterior Cruciate Ligament Rupture
Currently open trials in the same condition.
- NCT07030764 — Comparison of Arthrogenic Muscle Inhibition (AMI) After ACL Reconstruction in Patients With Conventional Rehabilitation · NA · recruiting
- NCT06973785 — Non-Narcotic Pain Control After ACL Reconstruction · Phase 3 · recruiting
- NCT07043569 — Clinical-randomized Trial of the Effect of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on · NA · recruiting
- NCT07009392 — Microbiological Molecular Profile of the Knee Joint During Primary Reconstruction or Revision Surgery of the ACL · NA · active not recruiting
- NCT06235736 — Do Patients With ACL Tears Demonstrate Weakness of the Soleus Muscle? · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03462823 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sandro Fucentese
- Last refreshed: 6 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03462823.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing